166 related articles for article (PubMed ID: 15846457)
1. In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.
Ekins S; Johnston JS; Bahadduri P; D'Souza VM; Ray A; Chang C; Swaan PW
Pharm Res; 2005 Apr; 22(4):512-7. PubMed ID: 15846457
[TBL] [Abstract][Full Text] [Related]
2. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
[TBL] [Abstract][Full Text] [Related]
3. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
Han HK; Rhie JK; Oh DM; Saito G; Hsu CP; Stewart BH; Amidon GL
J Pharm Sci; 1999 Mar; 88(3):347-50. PubMed ID: 10052994
[TBL] [Abstract][Full Text] [Related]
4. Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.
Sala-Rabanal M; Loo DD; Hirayama BA; Turk E; Wright EM
J Physiol; 2006 Jul; 574(Pt 1):149-66. PubMed ID: 16627568
[TBL] [Abstract][Full Text] [Related]
5. Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy.
Larsen SB; Omkvist DH; Brodin B; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS
ChemMedChem; 2009 Sep; 4(9):1439-45. PubMed ID: 19557803
[TBL] [Abstract][Full Text] [Related]
6. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
7. The extracellular pH dependency of transport activity by human oligopeptide transporter 1 (hPEPT1) expressed stably in Chinese hamster ovary (CHO) cells: a reason for the bell-shaped activity versus pH.
Fujisawa Y; Tateoka R; Nara T; Kamo N; Taira T; Miyauchi S
Biol Pharm Bull; 2006 May; 29(5):997-1005. PubMed ID: 16651734
[TBL] [Abstract][Full Text] [Related]
8. Structure-based model profiles affinity constant of drugs with hPEPT1 for rapid virtual screening of hPEPT1's substrate.
Sun L; Meng S
SAR QSAR Environ Res; 2016 Aug; 27(8):637-52. PubMed ID: 27586363
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Omkvist DH; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
[TBL] [Abstract][Full Text] [Related]
10. Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes.
Li K; Xu L; Kulkarni AA; Perkins DI; Haworth IS; Davies DL
Alcohol Clin Exp Res; 2008 May; 32(5):777-84. PubMed ID: 18336632
[TBL] [Abstract][Full Text] [Related]
11. A novel hPepT1 stably transfected cell line: establishing a correlation between expression and function.
Herrera-Ruiz D; Faria TN; Bhardwaj RK; Timoszyk J; Gudmundsson OS; Moench P; Wall DA; Smith RL; Knipp GT
Mol Pharm; 2004; 1(2):136-44. PubMed ID: 15832510
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
[TBL] [Abstract][Full Text] [Related]
13. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
14. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).
Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B
AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699
[TBL] [Abstract][Full Text] [Related]
15. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells.
Covitz KM; Amidon GL; Sadée W
Pharm Res; 1996 Nov; 13(11):1631-4. PubMed ID: 8956326
[TBL] [Abstract][Full Text] [Related]
16. Design of high-affinity peptide conjugates with optimized fluorescence quantum yield as markers for small peptide transporter PEPT1 (SLC15A1).
Bahadduri PM; Ray A; Khandelwal A; Swaan PW
Bioorg Med Chem Lett; 2008 Apr; 18(8):2555-7. PubMed ID: 18374571
[TBL] [Abstract][Full Text] [Related]
17. Discovery of non-glycoside sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening.
Wu JS; Peng YH; Wu JM; Hsieh CJ; Wu SH; Coumar MS; Song JS; Lee JC; Tsai CH; Chen CT; Liu YW; Chao YS; Wu SY
J Med Chem; 2010 Dec; 53(24):8770-4. PubMed ID: 21090651
[TBL] [Abstract][Full Text] [Related]
18. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K
Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721
[TBL] [Abstract][Full Text] [Related]
19. Protonation State of a Histidine Residue in Human Oligopeptide Transporter 1 (hPEPT1) Regulates hPEPT1-Mediated Efflux Activity.
Omori A; Fujisawa Y; Sasaki S; Shimono K; Kikukawa T; Miyauchi S
Biol Pharm Bull; 2021; 44(5):678-685. PubMed ID: 33952823
[TBL] [Abstract][Full Text] [Related]
20. hPEPT1 affinity and translocation of selected Gln-Sar and Glu-Sar dipeptide derivatives.
Eriksson AH; Elm PL; Begtrup M; Nielsen R; Steffansen B; Brodin B
Mol Pharm; 2005; 2(3):242-9. PubMed ID: 15934785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
